|
News out - Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIV
|
4
|
Zenith Epigenetics
|
Feb 22, 2022 08:50AM
|
|
More News Coverage on Global
|
12
|
Resverlogix Corp.
|
Feb 03, 2022 01:37PM
|
|
Re: Gonna be a multi billion dollar company soon imo get on board
|
6
|
Resverlogix Corp.
|
Feb 01, 2022 09:04PM
|
|
CBC Radio News Interview with Dr. Sweeney
|
7
|
Resverlogix Corp.
|
Feb 01, 2022 08:14AM
|
|
Re: More media
|
5
|
Resverlogix Corp.
|
Jan 24, 2022 11:03AM
|
|
"A Change is going to come"?
|
14
|
Resverlogix Corp.
|
Jan 07, 2022 03:39PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
6
|
Resverlogix Corp.
|
Dec 13, 2021 01:09PM
|
|
Re: Why
|
4
|
Resverlogix Corp.
|
May 14, 2021 09:05AM
|
|
Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA
|
7
|
Zenith Epigenetics
|
Mar 15, 2021 08:27AM
|
|
Re: ZHCLF trading
|
7
|
Zenith Epigenetics
|
Feb 08, 2021 02:39PM
|
|
M-Triact (Match Now)?
|
8
|
Resverlogix Corp.
|
Sep 25, 2019 09:36AM
|
|
Re: My opinion on the pre-market gap down in the bid/ask...
|
5
|
Resverlogix Corp.
|
Aug 21, 2019 09:47AM
|
|
Re: Reading between the lines in Management's comments
|
3
|
Resverlogix Corp.
|
May 01, 2019 04:01PM
|
|
Re: I'm out....let's close strong
|
5
|
Resverlogix Corp.
|
Mar 08, 2019 04:47PM
|
|
Researchers Successfully Treat Metastatic Cancer
|
5
|
Zenith Epigenetics
|
Nov 06, 2018 03:33PM
|
|
Re: Eligibility for registered accounts in Canada
|
2
|
Zenith Epigenetics
|
Aug 20, 2018 10:54AM
|
|
Re: Eligibility for registered accounts in Canada
|
4
|
Zenith Epigenetics
|
Aug 20, 2018 08:09AM
|
|
Re: Pre-market matching bids!! $1.81 !!!
|
5
|
Resverlogix Corp.
|
Jan 10, 2018 11:15AM
|
|
Re: TD Waterhouse-TFSA
|
2
|
Zenith Epigenetics
|
Dec 15, 2017 09:25AM
|
|
Re: TD Waterhouse-TFSA
|
5
|
Zenith Epigenetics
|
Dec 15, 2017 09:00AM
|
